EyePoint Still Has A Very Promising Future
EyePoint is on a steeply upward sloping growth path with two relatively new treatments and a third one on the way. However, the coronavirus pandemic is hobbling the growth path […]
EyePoint Pharmaceuticals Faces A Big Opportunity
The company has launched two products, DEXYCU and YUTIQ. Both have very substantial market potential, and orders are ramping fast. Due to a situation with its distributor, the ramp in […]
EyePoint Pharmaceuticals Is Eyeing 2 Big Market Opportunities
EyePoint Pharmaceuticals has just introduced two new treatments, YUTIQ and DEXYCU, both involve the slow release of steroids to prevent eye infections. Most of the elements for successful market penetration […]